EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Prevalence of Occult Hepatitis C Virus in Egyptian Patients with Chronic Lymphoproliferative Disorders

Samar Samir Youssef, Aml S Nasr, Taher El Zanaty, Rasha Sayed El Rawi, Mervat M Mattar

Hepatitis Research and Treatment · 12.12.2012 · 2012 · 1-6

DOI: 10.1155/2012/429784 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hepatitis Research and Treatment, erschienen am 12.12.2012. Verfasst von Samar Samir Youssef und 4 weiteren Autor:innen. Beteiligte Einrichtung: Microbial Biotechnology Department, National Research Centre, Cairo 12311, Egypt. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Occult hepatitis C virus infection (OCI) was identified as a new form of Hepatitis C virus (HCV), characterized by undetectable HCV antibodies and HCV RNA in serum, while HCV RNA is detectable in liver and peripheral blood cells only.

Aim

The aim of this study was to investigate the occurrence of OCI in Egyptian patients with lymphoproliferative disorders (LPDs) and to compare its prevalence with that of HCV in those patients. Subjects and Methods. The current study included 100 subjects, 50 of them were newly diagnosed cases having different lymphoproliferative disorders (patients group), and 50 were apparently healthy volunteers (controls group). HCV antibodies were detected by ELISA, HCV RNA was detected in serum and peripheral blood mononuclear cells (PBMCs) by reverse transcription polymerase chain reaction(RT-PCR), and HCV genotype was detected by INNO-LiPA.

Results

OCI was detected in 20% of patients group, compared to only 4% OCI in controls group. HCV was detected in 26% of patients group with a slightly higher prevalence. There was a male predominance in both HCV and OCI. All HCV positive patients were genotype 4.

Conclusion

Our data revealed occurrence of occult HCV infection in Egyptian LPD patients at a prevalence of 20% compared to 26% of HCV.

Autor:innen und Institutionen

  • Microbial Biotechnology Department, National Research Centre, Cairo 12311, Egypt.

Zitieren

APA

Youssef, S. S., Nasr, A. S., El Zanaty, T., El Rawi, R. S., & Mattar, M. M. (2012). Prevalence of Occult Hepatitis C Virus in Egyptian Patients with Chronic Lymphoproliferative Disorders. Hepatitis Research and Treatment, 2012, 1-6. https://doi.org/10.1155/2012/429784

Vancouver

Youssef SS, Nasr AS, El Zanaty T, El Rawi RS, Mattar MM. Prevalence of Occult Hepatitis C Virus in Egyptian Patients with Chronic Lymphoproliferative Disorders. Hepatitis Research and Treatment. 2012;2012:1-6. doi:10.1155/2012/429784

BibTeX
@article{Youssef2012,
  author = {Youssef, Samar Samir and Nasr, Aml S and El Zanaty, Taher and El Rawi, Rasha Sayed and Mattar, Mervat M},
  title = {Prevalence of Occult Hepatitis C Virus in Egyptian Patients with Chronic Lymphoproliferative Disorders},
  journal = {Hepatitis Research and Treatment},
  year = {2012},
  volume = {2012},
  pages = {1--6},
  doi = {10.1155/2012/429784}
}
Kostenlos starten →